甲基化DNA序列作为癌症生物标志物的临床应用：美国国立癌症研究所环境基因组学和风险评估网络（EDRN）与美国国家标准与技术研究院（NIST）关于标准、方法、检测、试剂及工具的联合研讨会
Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.
作者信息
Kagan Jacob, Srivastava Sudhir, Barker Peter E, Belinsky Steven A, Cairns Paul
机构信息
Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland, USA.
出版信息
Cancer Res. 2007 May 15;67(10):4545-9. doi: 10.1158/0008-5472.CAN-06-2888.
The workshop report, entitled Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint National Cancer Institute's Early Detection Research Network and National Institute of Standards and Technology Workshop, presents a summary of the main issues, current challenges, outcomes, and recommendations toward application of methylated DNA sequences as cancer biomarkers.
这份研讨会报告题为《迈向甲基化DNA序列作为癌症生物标志物的临床应用：美国国立癌症研究所早期检测研究网络与美国国家标准与技术研究院联合研讨会》，总结了将甲基化DNA序列用作癌症生物标志物的主要问题、当前挑战、成果及建议。
Zotero 插件